Why Intra-Cellular Therapies Was Weak This Week
What happened
Psychiatric and neurologic drugs developer Intra-Cellular Therapies(NASDAQ:ITCI) was a cold stock this week. After reporting its second-quarter results on Monday, the company’s shares sank and to date have not recovered; at Friday’s close,…
